Clinical Trial: Optimizing Treatment on Idiopathic Inflammatory Myopathies

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: Optimizing Treatment on Idiopathic Inflammatory Myopathies

Brief Summary:

As a T2T, our patients with idiopathic inflammatory myopathies will receive pulse therapies with methyprednisolone and/or human intravenous immunoglobulin, or only methyprednisolone at disease onset.

This scheme is an internal routine protocol of our Service.


Detailed Summary: To compare two groups of patients as described in Brief Summary.
Sponsor: University of Sao Paulo

Current Primary Outcome:

  • Physician Global Activity [ Time Frame: Six months ]
    This partially validated tool measures the global evaluation by the treating physician of the overall disease activity of the patient at the time of assessment using a 10 cm. visual analogue scale and a 5 point Likert scale.
  • Patient/Parent Global Activity - [ Time Frame: Six months ]
    This partially validated tool measures the global evaluation by the patient, or by the parent if the patient is a minor, of the patient's overall disease activity at the time of assessment using a 10 cm. visual analogue scale.
  • Manual Muscle Testing [ Time Frame: Six months ]
    This partially validated tool assesses muscle strength using manual muscle testing (MMT). A 0 - 10 point scale is proposed for use. An abbreviated group of 8 proximal, distal, and axial muscles performs similarly to a total of 24 muscle groups, and is also proposed for use for research studies.
  • Health Assessment Questionnaire [ Time Frame: Six months ]
    Define the health assessement questionnaire. Pontuaction: 0.00-3.00
  • Muscle Enzymes [ Time Frame: Six months ]
    This partially validated tool measures the serum activities of at least 2 of the 4 muscle-associated enzymes including creatine phosphokinase (CK), the transaminases (ALT, AST), lactate dehydrogenase (LD) and aldolase.
  • Myositis Disease Activity Assessment Tool [ Time Frame: Six months ]
  • Physician Global Activity - Visual Analogue Scale/Likert [ Time Frame: Six months ]
    This partially validated tool measures the global evaluation by the treating physician of the overall disease activity of the patient at the time of assessment using a 10 cm. visual analogue scale and a 5 point Likert scale.
  • Patient/Parent Global Activity - Visual Analogue Scale/Likert [ Time Frame: Six months ]
    This partially validated tool measures the global evaluation by the patient, or by the parent if the patient is a minor, of the patient's overall disease activity at the time of assessment using a 10 cm. visual analogue scale.
  • Muscle Strength Testing - Manual Muscle Testing (MMT) [ Time Frame: Six months ]
    This partially validated tool assesses muscle strength using manual muscle testing (MMT). A 0 - 10 point scale is proposed for use. An abbreviated group of 8 proximal, distal, and axial muscles performs similarly to a total of 24 muscle groups, and is also proposed for use for research studies.
  • Functional Assessment Tools - HAQ [ Time Frame: Six months ]
    Define the health assessement questionnaire. Pontuaction: 0.00-3.00
  • Laboratory - Muscle Enzymes [ Time Frame: Six months ]
    This partially validated tool measures the serum activities of at least 2 of the 4 muscle-associated enzymes including creatine phosphokinase (CK), the transaminases (ALT, AST), lactate dehydrogenase (LD) and aldolase.
  • Same as current

    Information By: University of Sao Paulo

    Dates:
    Date Received: March 9, 2017
    Date Started: January 2005
    Date Completion: January 2026
    Last Updated: March 24, 2017
    Last Verified: March 2017